Warner Chilcott plc (WCRX) Thursday announced the United States Food and Drug Administration or FDA approval of a new oral contraceptive, norethindrone acetate and ethinyl estradiol chewable tablets and ferrous fumarate tablets, for the prevention of pregnancy. The product does not currently have a brand name.
The new oral contraceptive which is indicated for use by women of reproductive age to prevent pregnancy, is expected to be commercially launched in early August 2013.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.